The biology of meningiomas

Journal of Neuro-Oncology

Volumn 29, Issue 3, 1996, Pages 207-216

  McCutcheon, Ian E ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Angiogenesis; Biology; Estrogen; Growth factors; Invasion; Meningioma; Progesterone; Tissue culture

Indexed keywords

ANDROGEN; ANGIOGENIC FACTOR; ESTROGEN; GROWTH FACTOR; PROGESTERONE; PROTEINASE;

CANCER CELL CULTURE; CANCER INVASION; CONFERENCE PAPER; CYTOLOGY; HUMAN; MENINGIOMA; MOLECULAR BIOLOGY; TUMOR GROWTH; TUMOR VASCULARIZATION;

FEMALE; GONADAL STEROID HORMONES; GROWTH SUBSTANCES; HUMANS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; TUMOR CELLS, CULTURED;

EID: 0030036012     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00165650     Document Type: Conference Paper

References (60)

1. Bland JOW, Russell DS: Histological types of meningiomata and a comparison of their behaviour in tissue culture with that of certain normal human tissues. J Pathol Bacteriol 47: 291-309, 1938
2. Korsgaard R, Clausen OP, Thorud E: Establishment of a human meningeal cell line in culture. Anticancer Res 4: 83-90, 1984
3. Tanaka K, Sato C, Maeda Y, Koike M, Matsutani M, Yamada K, Miyaki M: Establishment of a human malignant meningioma cell line with amplified c-myc oncogene. Cancer 64: 2243-2249, 1989
4. Lee WH: Characterization of a newly established malignant meningioma cell line of the human brain: IOMM-Lee. Neurosurgery 27: 389-396, 1990
5. Kepes JJ: Meningiomas: Biology, Pathology, and Differential Diagnosis. Masson, New York, 1982, pp 10-11
6. Medkhour A, Van Roey M, Sobel RA, Fingert HJ, Martuza RL: Implantation of human meningiomas into the sub-renal capsule of the nude mouse: a model for studies of tumor growth. J Neurosurg 71: 545-550, 1989
7. Bickerstaff ER, Small JM, Guest IA: The relapsing course of certain meningiomas in relation to pregnancy and menstruation. J Neurol Neurosurg Psychiatry 21: 89-91, 1958
8. Rubinstein AB, Schein M, Reichenthal E: The association of carcinoma of the breast with meningioma. Surg Gynecol Obstet 169: 334-336, 1989
9. Donnell MS, Meyer GA, Donegan WL: Estrogen receptor protein in intracranial meningiomas. J Neurosurg 50: 499-502, 1979
10. Martuza RL, MacLaughlin DT, Ojemann RG: Specific estradiol binding in schwannomas, meningiomas, and neurofibromas. Neurosurgery 9: 665-671, 1981
11. Martuza RL, Miller DC, MacLaughlin DT: Estrogen and progesterone binding by cytosolic and nuclear fractions of human meningioma. J Neurosurg 62: 750-756, 1985
12. Tilzer LL, Plapp FV, Evans JP, Stone D, Alward K: Steroid receptor proteins in human meningiomas. Cancer 49: 633-636, 1982
13. Lee L-S, Chi C-W, Chang T-J, Chou M-D, Liu H-C, Liu T-Y: Steroid hormone receptors in meningiomas of Chinese patients. Neurosurgery 25: 541-545, 1989
14. Markwalder TM, Markwalder RV, Zava DT: Estrogen and progestin receptors in meningiomas: clinicopathologic correlations. Clin Neuropharmacol 7: 366-374, 1984
15. Poisson M, Pertuiset BF, Hauw JJ, Philippon J, Buge A, Moguilewsky M, Philibert D: Steroid hormone receptors in human meningiomas, gliomas, and brain metastases. J Neurooncol 1: 179-189, 1983
16. Blankenstein MA, van der Meulen Dijk C, Thijssen JHH: Assay of oestrogen and progestin receptors in human meningioma cytosols using immunological methods. Clin Chim Acta 165: 189-195, 1987
17. Piantelli M, Rinelli A, Macri E, Maggiano N, Larocca LM, Sceratti M, Roselli R, Iacoangeli M, Scambia G, Capelli A: Type II estrogen binding sites and antiproliferative activity of quercetin in human meningiomas. Cancer 71: 193-198, 1993
18. Jay JR, MacLaughlin DT, Riley KR, Martuza RL: Modulation of cell growth by sex steroid hormones in vitro. J Neurosurg 62: 757-762, 1985
19. Olson JJ, Beck DW, Schlechte J, Loh PM: Hormonal manipulation of meningiomas in vitro. J Neurosurg 65: 99-107, 1986
20. Zava DT, Markwalder TM, Markwalder RV: Biological expression of steroid hormone receptors in primary meningioma cells in monolayer culture. Clin Neuropharmacol 7: 382-388, 1984
21. Schrell UMH, Adams EF, Fallbusch R, Greb R, Jirikowski G, Prior R, Ramalho-Ortigao FJ: Hormone dependency of cerebral meningiomas. Part I: female sex steroid receptors and their significance as specific markers for adjuvant medical therapy. J Neurosurg 73: 743-749, 1990
22. Moguilewsky M, Pertuiset BF, Verzat C, Philibert D, Philippon J, Poisson M: Cytosolic and nuclear sex steroid receptors in meningiomas. Clin Neuropharmacol 7: 375-381, 1984
23. Brandis A, Mirzai S, Tatagiba M, Walter GF, Samii M, Ostertag H: Immunohistochemical detection of female sex hormone receptors in meningiomas: correlation with clinical and histological features. Neurosurgery 33: 212-217, 1993
24. Perrot-Applanat M, Groyer-Picard MT, Kujas M: Immunocytochemical study of progesterone receptor in human meningioma. Acta Neurochir 115: 20-30, 1993
25. Schwartz MR, Randolph RL, Cech DA, Rose JE, Panko WB: Steroid hormone binding macromolecules in meningiomas: failure to meet criteria of specific receptors. Cancer 53: 922-927, 1984
26. Adams EF, Schrell UMH, Fahlbusch R, Thierauf P: Hormonal dependency of cerebral meningiomas. Part 2. In vitro effect of steroids, bromocriptine, and epidermal growth factor on growth of meningiomas. J Neurosurg 73: 750-755, 1990
27. Maiuri F, Montagnani S, Gallicchio B, Caradente M, Lanza GG, D'Andrea F: Estrogen and progesterone sensitivity in cultured meningioma cells. Neurol Res 11: 9-13, 1989
28. Olson JJ, Beck DW, Schlechte J, Loh PM: Effect of the antiprogesterone RU-38486 on meningiomas implanted in nude mice. J Neurosurg 66: 584-587, 1987
29. Blankenstein MA, van 't Verlaat JW, Croughs RJM: Hormone dependency of meningiomas (letter). Lancet 1: 1381, 1989
30. Olson JJ, Beck DW, MacIndoe JW, Min-Loh P: Androgen receptors in meningiomas. Cancer 61: 952-955, 1988
31. Maxwell M, Galanopoulos T, Neville-Golden J, Antoniades HN: Expression of androgen and progesterone receptors in primary human meningiomas. J Neurosurg 78: 456-462, 1993
32. Carroll RS, Zhang J, Dashner K, Sar M, Wilson EM, Black PM: Androgen receptor expression in meningiomas. J Neurosurg 82: 453-460, 1995
33. Weisman AS, Villemure JG, Kelly PA: Regulation of DNA synthesis and growth of cells derived from primary human meningiomas. Cancer Res 46: 2545-2550, 1986
34. Black PM, Carroll R, Glowacka D, Riley K, Dashner K: Platelet-derived growth factor expression and stimulation in human meningiomas. J Neurosurg 81: 388-393, 1994
35. Jensen RL, Origitano TC, Lee YS, Weber M, Wuurster RD: In vitro growth inhibition of growth factor-stimulated meningioma cells by calcium channel antagonists. Neurosurgery 36: 365-374, 1995
36. Harsh GR, Keating MT, Escobedo JA, Williams LT: Platelet derived growth factor (PDGF) autocrine components in human tumor cell lines. J Neuro-Oncol 8: 1-12, 1990
37. Delta A, Kenny BG, Smith C, Logan A, Hitchcock E: Correlation of proto-oncogene expression and proliferation in meningiomas. Neurosurgery 33: 1065-1074, 1993
38. Sanson M, Richard S, Delattre O, Poliwka M, Mikol J, Philippon J, Thomas G: Allelic loss on chromosome 22 correlates with histopathological predictors of recurrence of meningiomas. Int J Cancer 50: 391-394, 1992
39. Glick RP, Unterman TG, Woude MV, Blaydes LZ: Insulin and insulin-like growth factors in central nervous system tumors. Part V: Production of insulin-like growth factors I and II in vitro. J Neurosurg 77: 445-450, 1992
40. 125I-insulin-like growth factor-I binding to human meningiomas and on proliferation of meningioma cells. J Neurosurg 80: 502-509, 1994
41. Johnson MD, Federspiel CF, Gold LI, Moses HL: Transforming growth factor-b and transforming growth factor-b receptor expression in human meningioma cells. Am J Pathol 141: 633-642, 1992
42. Nitta T, Sato K, Okumura K: Transforming growth factor (TGF)-b like activity of intracranial meningioma and its effect on cell growth. J Neurol Sci 101: 19-23, 1991
43. Koper JW, Markstein R, Kohler C, Kwekkeboom DJ, Avezaat CJ, Lamberts SW, Reubi JC: Somatostatin inhibits the activity of adenylate cyclase in cultured human meningioma cells and stimulates their growth. J Clin Endocrinol Metab 74: 543-547, 1992
44. Reubi JC, Maurer R, Klijn JLM: High incidence of somatostatin receptors in human meningiomas and biochemnical characteristics. J Clin Endocrinol Metab 63: 433-438, 1986
45. Schrell UMH, Nomikos R Fahlbusch R: Presence of dopamine D1 receptors and absence of dopamine D2 receptors in human cerebral meningioma tissue. J Neurosurg 77: 288-294, 1992
46. Jiminez-Hakim E, El-Azouzi M, Black PMcL: The effect of prolactin and bombesin on the growth of meningioma-derived cells in monolayer culture. J Neuro-Oncol 16: 185-190, 1993
47. Koper JW, Zwarthoff EC, Hagemeijer A, Braakman R, Avezaat CJ, Berstrom M, Lamberts SW: Inhibition of the growth of cultured human meningioma cells by recombinant interferon-a. Eur J Cancer 27: 416-419, 1991
48. Kohn EC, Liotta LA: Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res 55: 1856-1862, 1995
49. R 92,000 type IV collagenase in human brain tumors. Cancer Res 53: 2208-2211, 1993
50. Nakagawa T, Kubota T, Kabuto M, Sato K, Kawano H, Hayakawa T, Okada Y: Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg 81: 69-77, 1994
51. Weindel K, Moringlane JR, Marm_ D, Weich HA: Detection and quantification of vascular endothelial growth factor/vascular permeability factor in brain tumor tissue and cyst fluid: the key to angiogenesis. Neurosurgery 35: 439-449, 1994
52. Samoto K, Ikezaki K, Ono M, Shono T, Kohno K, Kuwano M, Fukui M: Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res 55: 1189-1193, 1995
53. Dumanski JP, Rouleau GA, Nordenskjold M, Collins VP: Molecular genetic analysis of chromosome 22 in 81 cases of meningioma. Cancer Res 50: 5863-5867, 1990
54. Sanson M, Richard S, Delatre O: Allelic loss on chromosome 22 correlates with histopathologic predicators of recurrence of meningiomas. Int J Cancer 50: 391-394, 1992
55. Vagner-Capodano AM, Grisoli F, Gambarelli D: Correlation between cytogenetic and histopathologic findings in 75 human meningiomas. Neurosurgery 32: 892-900, 1993
56. Maxwell M, Galanopoulos T, Hedley-White ET, Black PM, Antoniades HN: Human meningiomas co-express platelet-derived growth factor (PDGF) and PDGF-receptor genes and their protein products. Int J Cancer 46: 16-21, 1990
57. Carstens C, Meese E, Zang KD, Blin N: Human K-ras oncogene expression in meningiomas. Cancer Lett 43: 37-41, 1988
58. Diedrich U, Eckermann O, Schmidtke J: Rare Ha-ras and c-mos alleles in patients with intracranial tumors. Neurology 38: 587-589, 1988
59. Kazumoto T, Tamura M, Hoshimo H, Yuasa Y: Enhanced expression of the sis and c-myc oncogenes in human meningiomas. J Neurosurg 72: 786-791, 1990
60. Riva R, Larizza L: Expression of c-sis and c-fos genes in human meningiomas and neurinomas. Int J Cancer 51: 873-877, 1992